Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stig Lenhoff

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Blood Cancer Journal|November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectSaad Z Usmani, Antje Hoering, Michele Cavo, et al.
British Journal of Haematology|April 29, 2006
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study GroupStig Lenhoff, Martin Hjorth, Jan Westin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 25, 2023
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort studyThomas Silfverberg, Christina Zjukovskaja, Per Ljungman, et al.
Cytometry. Part B, Clinical Cytometry|June 10, 2010
Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myelomaHans E Johnsen, Martin Bøgsted, Tobias W Klausen, et al.
Bone Marrow Transplantation|September 20, 2019
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixaforCurly Morris, Christian Chabannon, Tamas Masszi, et al.
Haematologica|September 8, 2006
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantationStig Lenhoff, Martin Hjorth, Ingemar Turesson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationAli Bazarbachi, Myriam Labopin, Mahmoud Aljurf, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Bone Marrow Transplantation|November 13, 2021
Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational studyJohannes Schetelig, Jennifer Hoek, Stephan Stilgenbauer, et al.
Bone Marrow Transplantation|August 18, 2020
Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational studyJohannes Schetelig, Jennifer Hoek, Stephan Stilgenbauer, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Blood Cancer Journal|November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectSaad Z Usmani, Antje Hoering, Michele Cavo, et al.
British Journal of Haematology|April 29, 2006
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study GroupStig Lenhoff, Martin Hjorth, Jan Westin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 25, 2023
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort studyThomas Silfverberg, Christina Zjukovskaja, Per Ljungman, et al.
Cytometry. Part B, Clinical Cytometry|June 10, 2010
Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myelomaHans E Johnsen, Martin Bøgsted, Tobias W Klausen, et al.
Bone Marrow Transplantation|September 20, 2019
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixaforCurly Morris, Christian Chabannon, Tamas Masszi, et al.
Haematologica|September 8, 2006
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantationStig Lenhoff, Martin Hjorth, Ingemar Turesson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationAli Bazarbachi, Myriam Labopin, Mahmoud Aljurf, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Bone Marrow Transplantation|November 13, 2021
Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational studyJohannes Schetelig, Jennifer Hoek, Stephan Stilgenbauer, et al.
Bone Marrow Transplantation|August 18, 2020
Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational studyJohannes Schetelig, Jennifer Hoek, Stephan Stilgenbauer, et al.
Pageof 8